Skip to content

Mini Thoracoscopy vs Semirigid Thoracoscopy in Exudative Pleural Effusions

Rigid 'Mini-thoracoscopy' vs Semirigid Thoracoscopy in Undiagnosed Exudative Pleural Effusions : A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02851927
Acronym
MIST
Enrollment
73
Registered
2016-08-02
Start date
2016-06-30
Completion date
2018-09-30
Last updated
2018-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Effusion

Brief summary

Undiagnosed pleural effusion is a diagnostic dilemma especially in exudative pleural effusions (EPE). 20-40 % are unable to be attributed to a specific diagnosis, even after thoracentesis and closed pleural biopsy. Thoracoscopy has been demonstrated to increase the diagnostic yield in undiagnosed EPE. The diagnostic yield of thoracoscopy in malignant and TB pleural effusion ranges from 91% to 94% and 93% to 100%, respectively. Rigid thoracoscopy has traditionally been the modality of choice. The recently introduced semirigid thoracoscope provides ease of handling like a flexible bronchoscope. However, there are concerns about the diagnostic yield of semi-rigid thoracoscopy when compared with rigid thoracoscopy. According to the available literature, the yield of semirigid and rigid thoracoscopy is almost similar if adequate pleural biopsy is obtained. However there are concerns that with semi-rigid thoracoscope, there might be greater incidence of inability to obtain adequate pleural biopsy. On the other hand, the use of conventional rigid thoracoscope may be associated with greater procedure related pain.Mini-Thoracoscopy is a newer rigid thoracoscopy instrument which is smaller in diameter (5.5 mm) and may allow pleural biopsy with a smaller incision. There is scant literature on its utility. The investigators hereby propose to undertake a randomized comparison of rigid 'mini thoracoscope' vs semi rigid thoracoscope in undiagnosed pleural effusions.

Detailed description

Patients meeting the inclusion criteria and giving prior consent for the study shall be randomised. The randomization sequence will be computer generated with variable block size and the assignments will be placed in opaque sealed envelopes. All patients will undergo hemogram, liver and renal function tests, coagulation profile, an electrocardiogram and Computed tomography (CT) of the chest before entering the study. Chest ultrasound will be performed in all patients to evaluate the rib spaces, amount of pleural fluid and for selection of the entry point. Instruments The semi-rigid thoracoscope to be used is the autoclavable Olympus LTF-160 (Olympus, Tokyo, Japan) thoracoscope with 2.8 mm inner channel diameter and 7 mm outer diameter. The forceps is flexible forceps with alligator jaw with spike cusps, 2.8 mm of the outer diameter. The rigid mini thoracoscope is the Richard Wolf 5.5 mm operating endoscope with the working channel. Thoracoscopy technique Thoracoscopy will be performed in the interventional pulmonology lab. Patients shall be fasting for solids for 8 hours and for liquids 6 hours. Patients shall be having continuous monitoring of blood pressure, pulse rate, and oxygen saturation. Topical anesthesia will be achieved by infiltrating 2% lidocaine locally at the incision site. The procedure shall be performed under conscious sedation and analgesia using a combination of midazolam and intravenous fentanyl. An incision shall be made at the site of maximum fluid thickness as assessed by pre-procedural USG chest, with the patient in lateral decubitus position and involved side upward. After incision, the appropriately sized trocar shall be placed through the skin into the pleural space. The thoracoscope shall be inserted through the trocar. The pleural surfaces shall then be thoroughly inspected. A minimum of 6-8 pleural biopsy samples shall be obtained by semi-rigid thoracoscope and at least 4 with rigid mini-thoracoscope. Samples shall be sent for histopathological analysis and mycobacterial cultures. At the end of the procedure, a chest tube shall be placed and removed subsequently. All patients shall be followed up for a period of six months from the time of procedure if non-specific inflammation/ fibrinous pleuritis is the diagnosis or no definitive diagnosis is made during that time. Statistical analysis: Data shall be expressed as mean ± standard deviation (SD), or percentage. Differences in continuous variables between the two groups shall be compared using Student's t test (or Mann-Whitney U test); while differences in categorical data shall be compared using the chi-square test (or Fisher's exact test). A p value of less than 0.05 shall be considered statistically significant.

Interventions

PROCEDUREMini Thoracoscopy

Pleural biopsy using rigid mini thoracoscope

Pleural biopsy using semirigid thoracoscope

Sponsors

All India Institute of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years Presence of undiagnosed exudative pleural effusion as determined by the criteria detailed by Light et al where a specific diagnosis was not obtained after initial cytological and/or microbiological examinations. Adequate rib spaces for successful performance of thoracoscopy as judged by clinical examination Adequate pleural fluid space as judged by pre-procedural USG chest

Exclusion criteria

1. Pregnancy 2. Coagulopathy (platelet count \< 50000/mm3, INR \> 1.5) 3. Unstable hemodynamic status ( SBP \> 180, DBP\> 100 or SBP\< 90 mm Hg / heart failure 4. Myocardial infarction or unstable angina in the last 6 wk 5. Hypoxemia not correctable with low flow oxygen (SpO2 \<90% despite low flow oxygen @ 1-2 l/min) 6. Extensive rib crowding as judged by clinical examination 7. Extensive adhesions and lack of pleural space on USG chest 8. Refusal of consent

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic YieldThrough study completion, an average of 1 yearProportion of diagnostic biopsies in the two arms

Secondary

MeasureTime frameDescription
Procedural painThrough study completion, an average of 1 yearPatient rated procedural pain on Visual Analogue Scale
Operator rated overall procedure satisfactionThrough study completion, an average of 1 yearOperator rated overall procedure satisfaction on Visual Analogue Scale
Biopsy SizeThrough study completion, an average of 1 yearMean size of biopsy obtained during pleural biopsy procedure
Alternate equipmentThrough study completion, an average of 1 yearRequirement of conversion to alternate equipment for pleural biopsy
Image qualityThrough study completion, an average of 1 yearOperator rated image quality of pleural visualization (VAS)
Sedation doseThrough study completion, an average of 1 yearComparison of sedative and analgesic agent doses between the two groups
ComplicationsThrough study completion, an average of 1 yearComplications related to the procedure
Operator rated painThrough study completion, an average of 1 yearOperator rated procedural pain on Visual Analogue Scale

Other

MeasureTime frameDescription
Expectation of diagnostic biopsyThrough study completion, an average of 1 yearExpectation that biopsy will be diagnostic on Visual Analogue Scale
Ease of manoeuvring thoracoscopeThrough study completion, an average of 1 yearEase of scope maneuvering on Visual Analogue Scale
Ease of biopsyThrough study completion, an average of 1 yearEase of obtaining pleural biopsy on visual analogue scale
Operator rated pain on scope manipulationThrough study completion, an average of 1 yearOperator rated pain on scope manipulation on Visual analogue scale (VAS)

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026